Web Analytics

3 Latest Announced Rounds

  • $2,500,000
    Unknown

    1 Investors

    Services for Renewable Energy
    Nov 22nd, 2024
  • $1,447,585
    Seed
    Design Services
    Nov 22nd, 2024
  • $45,000,000
    Series C

    1 Investors

    Renewable Energy Semiconductor Manufacturing
    Nov 22nd, 2024
$2,199.23M Raised in 91 Funding Rounds in the past 7 Days - View All

Funding Round Profile

ImmunoScape

start up
Singapore - Singapore
  • 26/09/2022
  • Unknown
  • $14,000,000

ImmunoScape is a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR cell therapies in the field of oncology. The company's proprietary Deep Immunomics technology platform enables highly sensitive, large-scale mining and immune profiling of T cells in cancer patient samples to identify novel, therapeutically relevant TCRs across multiple types of solid tumors. ImmunoScape has multiple discovery programs ongoing and will be progressing towards IND-enabling studies and entry into the clinic.

To learn more, visit us at immunoscape.com and follow us on Twitter @immunoscape.


Related People

Choon-Peng (Choon) NgFounder

Choon-Peng (Choon) Ng Singapore - Singapore

General Management. Cross functional and cross geography experience.